JEFFREY A SCHWARTZ

CIK 1204970 · Chief Executive Officer · last filed 2011-06-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$924.7K

Companies

2

Total Filings

17

Lifetime Open-Market Net

-$687.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRTS Director 133,056 $6.95 $924.7K -$687.8K 14 2011-06-03
Protagenic Therapeutics, Inc.\new (ATRN) Delisted Chief Executive Officer 3,892 $0 2 2010-01-29

Recent Filings · Page 2 of 2

17 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2010-08-11 PRTS Mixed -$50.8K EDGAR
2010-01-29 Protagenic Therapeutics, Inc.\new (ATRN) Delisted Grant (A) $0 EDGAR
2009-06-30 Protagenic Therapeutics, Inc.\new (ATRN) Delisted Grant (A) +3,892 $0 EDGAR
2009-05-08 PRTS Grant (A) $0 EDGAR
2008-12-04 Other (J) $0
2008-05-06 PRTS Grant (A) $0 EDGAR
2007-10-24 PRTS Grant (A) $0 EDGAR
Showing 1117 of 17
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.